Search

Haematology

At the haematology department, people are treated for blood disorders, including benign and malignant conditions affecting the blood, bone marrow and lymph nodes.

Appointments

Appointment based on:

Address

UZ Leuven gasthuisberg campus
Dienst hematologie
Herestraat 49
3000 Leuven
Getting there and services

What can you contact us for?

Diseases and treatments

Overview of the diseases and treatments for which you can come to us.

Brochures

Overview of our brochures.

Klinische studies

Klinische studies zijn een essentieel onderdeel van de dienst hematologie. Ze dragen bij aan de ontwikkeling van nieuwe behandelingen voor bloedziekten en aan de verbetering van de medische zorg. Via deze website informeren we patiënten, zorgverleners en onderzoekers over lopende studies en de mogelijkheden tot deelname.

Research

Via studies kunnen we patiënten op de meest innovatieve manier behandelen, voor nieuwe geneesmiddelen en behandelingen veralgemeend worden toegepast. Daarnaast investeren we in fundamenteel wetenschappelijke en translationele onderzoeksprojecten om tot nieuwe inzichten te komen.

Voor apothekers

Hoe moet u PAXLOVID bestellen? Lees meer op de website van het KCE.

Departments

Dagziekenhuis 6

This day hospital sees patients from the disciplines of general medical oncology, gynecology and hematology.

Dagziekenhuis 10

At this day hospital, patients come to have a blood component such as blood cells or plasma removed, exchanged, or collected.

Hospitalisatie 20

This isolation ward houses patients with haematological disorders such as acute myeloid or lymphatic leukaemia and patients admitted for intensive chemotherapy or allogeneic stem cell transplantation.

Hospitalisatie 44

Patients with haematological disorders are admitted to this ward.

Support our research

Fund professor Marc Boogaerts

The Fund Professor Marc Boogaerts combines the funds Sofhea and Sofhea Cruh under a new name, which is fantastic news for the many blood stem cell transplant patients now and in the future. Other patients will also be helped by basic stem cell research.
Support this fund

Fund Jos and Mieke Vandevordt-Gaul for the pathogenesis of rare lymphomas

Thanks in part to the fund's support, young, talented PhD students can get down to work. Together with the specialists at UZ Leuven, they come closer, via genetic-molecular research, to the genesis mechanisms of rare lymphomas and thus to better treatments.
Support this fund

Fund Tom Debackere for lymphoma research

Thanks to the support of an initiative such as the Tom Debackere Fund, researchers can gain a better understanding of lymphoma and talented young scientists can receive the financial support they need to help significantly improve the fate of these patients.
Support this fund

Fund for research into Multiple Myeloma - for MM

There is still no effective treatment for many plasma cell diseases. Scientific research is providing us with new insights into these rare diseases and their treatments. In order to develop better treatments, it is necessary to have a good understanding of the mechanisms involved in their development. This requires a great deal of scientific research.
Support this fund

Janssen Fund for Haematological Research

Our research into new therapeutic options will receive very welcome support from this fund for haematological research. It should also help us to choose the right drug for the right patient and to find an appropriate response when the patient does not react as expected.
Support this fund

Joris Henderickx LCH Research Fund

The rare and little-known disease Langerhans-Cel-Histiocytosis occurs mainly in young children and is in some cases life-threatening. Contact with fellow sufferers, information about the disease and treatment methods, and fundraising for scientific research are the main objectives of the association.
Support this fund

Patient-tailored cancer immunotherapy

Each body reacts differently to immunotherapy. That is why our research group believes in a personalized approach. With your support, we want to help more cancer patients in the future.
Support this fund

Stefanie’s Roses Fund

Thanks to the proceeds of numerous benefit campaigns and donations from sympathizers, this fund succeeds in accelerating research into lymphoma.
Support this fund

Thrombotic thrombocytopenic purpura (TTP) Fund

The fund aims to further expand and deepen scientific research into this rare disease by elucidating the unknown cause of the development of TTP, developing a less invasive treatment for the disease and developing a hitherto non-existent rapid diagnostic test.
Support this fund

Fund ME TO YOU

With the creation of this fund, we are consolidating the scientific branch of the ME TO YOU Foundation in support of blood cancer research and hope to add small pieces to the puzzle to eventually unravel this complex disease.
Support this fund

News and events

New technique helps detect large-scale genetic variations in leukaemia

22 December 2021
The Leuven centre for human genetics is one of the first genetic centres in the world that applies a new genetic test. The technique is called ‘optical genome mapping’ and can detect large genetic variations on chromosome level. Today, the test is already being used for diagnosing leukaemia.

New genetic anomaly and therapeutic target discovered in rare lymphoma

13 August 2021
UZ Leuven and KU Leuven researchers have discovered a new genetic anomaly which lies at the root of a rare lymphoma. The discovery opens up new perspectives for a better treatment.

Shorter antibiotic treatment just as safe for patients with a reduced immune system

10 June 2021
For patients with reduced immunity as a result of intensive chemotherapy the antibiotic treatment can shortened safely as demonstrated in a trial on neutropenic fever by researchers at UZ Leuven and Erasmus Medisch Centrum in Rotterdam.
Load more news and events
Last edit: 5 february 2026